5040-09-5

Usage

Uses

Used in Organic Synthesis:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used as an intermediate in the synthesis of various organic compounds for [application reason] its unique structural features that allow for further chemical modifications and functionalization.
Used in Pharmaceutical Industry:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used as a building block in the development of complex carbohydrate-based drugs for [application reason] its ability to form specific interactions with biological targets, such as receptors and enzymes.
Used in Chemical Research:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used as a research tool in the study of carbohydrate chemistry and biochemistry for [application reason] its distinctive properties that can provide insights into the structure-function relationships of carbohydrates.
Used in Material Science:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used in the development of novel materials with specific properties, such as stimuli-responsive hydrogels or drug delivery systems, for [application reason] its potential to form complex architectures and interactions with other molecules.

Upstream product

• 108-24-7 acetic anhydride 
• 4613-62-1 3-deoxy-1,2;5,6-di-O-isopropylidene-α-D-glucofuranoside 
• 1082903-53-4 (3aR,5S,6aR)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxole 
• 350255-13-9 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 36204-29-2 3-deoxy-D-ribo-hexopyranose 

Downstream Products

• 915286-33-8 S-phenyl 2,4,6-tri-O-acetyl-3-deoxy-β-D-ribo-thiohexopyranoside 
• 171626-60-1 2,4-dinitrophenyl-3-deoxy-β-D-ribo-hexopyranoside 
• 262607-34-1 2,4-dinitrophenyl-2,4,6-tri-O-acetyl-3-deoxy-β-D-ribo-hexopyranoside 

Relevant academic research and scientific papers

Synthesis of 1,5-Anhydro-D-fructose derivatives and evaluation of their inflammasome inhibitors

Synthesis of several 1,5-Anhydro-D-fructose (1,5-AF) derivatives to evaluate inhibitory activities of the inflammasome was carried out. Recently, 1,5-AF reported to suppress the inflammasome, although with only low activity. We focused on the hydration of

BICYCLIC MORPHOLINO COMPOUNDS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM

The present invention provides bicyclic morpholino compounds and oligomeric compounds prepared therefrom. More particularly, incorporation of one or more of the bicyclic morpholino compounds into an oligomeric compound is expected to enhance one or more p

HALOGENATED DIDEOXY SUGAR DERIVATES, PREPARATION METHOD AND APPLICATION THEREOF

A halogenated dideoxy sugar derivative, having the following general structure I wherein X is halogen, R1 and R2 are H or Br; R3 and R4 are OH or OAc. The compounds 1-14 of the current invention has strong inhib

HALOGENATED DIDEOXY SACCHARIDE DERIVATIVES, PREPARATION METHOD AND USE THEREOF

The current invention is related to a halogenated dideoxy sugar derivative, wherein that the derivative has the following general structure I wherein X is halogen, or R1 and R2 are H or Br; R3 and R4 are OH or O

Development of carbohydrate-derived inhibitors of acid sphingomyelinase

The acid sphingomyelinase is an emerging drug target, especially for inflammatory lung diseases. Presently, there are no directly-acting potent inhibitors available for cell-based studies. The potent inhibitor phosphatidylinositol-3,5-bisphosphate (PtdIns3,5P2) is not only unsuited for cell culture studies, but also does not provide hints for further structural improvements. In the SAR study described here, we replaced the inositolphosphate moiety by a carbohydrate derivative and the phosphatidic acid residue by an alkylsulfone ester. The resulting compound is more active than its parent compound and offers new means for further structural modification.

Synthesis of UDP-glucose derivatives modified at the 3-OH as potential chain terminators of β-glucan biosynthesis

A series of UDP-d-glucose derivatives and precursors that have been modified at C-3 were synthesised from d-glucose as potential chain terminators of β-glucan biosynthesis. None of the UDP-derivatives or the precursors tested displayed significant anti-fungal activity in a series of germination assays on the dermatophyte Trichophyton rubrum.